Norinchukin Bank The Has $2.34 Million Holdings in Kenvue Inc. $KVUE

Key Points

• Norinchukin Bank The increased its stake in Kenvue Inc. by 14.9% during the first quarter, holding a total of 97,754 shares valued at approximately $2.34 million.
• Analysts have decreased their price targets for Kenvue, with Bank of America lowering it from $27.00 to $25.00 and Citigroup from $24.50 to $22.00, indicating a mixed outlook on the stock.
• Kenvue announced a quarterly dividend of $0.2075 per share, representing an increase from the previous $0.21, with a dividend yield of 3.8%.

Norinchukin Bank The increased its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 14.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,754 shares of the company's stock after purchasing an additional 12,690 shares during the quarter. Norinchukin Bank The's holdings in Kenvue were worth $2,344,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of KVUE. Fulton Bank N.A. raised its holdings in Kenvue by 0.6% during the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after buying an additional 465 shares during the period. Scott & Selber Inc. increased its holdings in shares of Kenvue by 0.4% in the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after purchasing an additional 475 shares during the period. Wealth Alliance LLC increased its holdings in shares of Kenvue by 1.6% in the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after purchasing an additional 486 shares during the period. Everett Harris & Co. CA increased its holdings in shares of Kenvue by 1.4% in the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after purchasing an additional 500 shares during the period. Finally, Byrne Asset Management LLC increased its holdings in shares of Kenvue by 1.0% in the 1st quarter. Byrne Asset Management LLC now owns 63,467 shares of the company's stock valued at $1,522,000 after purchasing an additional 621 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on KVUE shares. Bank of America lowered their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Tuesday, July 15th. Royal Bank Of Canada lowered their price target on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research note on Friday, August 8th. Citigroup lowered their price target on Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a research note on Tuesday, July 15th. Canaccord Genuity Group lowered their price target on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Barclays lowered their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, July 15th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $24.38.

Kenvue Stock Performance

Kenvue stock traded down $0.01 during trading hours on Wednesday, reaching $20.78. 12,078,510 shares of the company were exchanged, compared to its average volume of 17,275,008. The firm has a market cap of $39.87 billion, a price-to-earnings ratio of 28.08, a PEG ratio of 3.04 and a beta of 0.83. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average of $21.50 and a 200 day moving average of $22.45. Kenvue Inc. has a 12 month low of $19.75 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company's revenue was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th will be issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.0%. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 13th. Kenvue's dividend payout ratio is presently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.